FDA grants priority review for AbbVie'... - Hepatitis C Support

Hepatitis C Support

681 members359 posts

FDA grants priority review for AbbVie's pan-genotypic HCV regimen

HFIAdmin profile image
0 Replies

It has been weeks since AbbVie's New #Drug Application for glecaprevir/pibrentasvir. At last, the #FDA replied and approved the new regimen. Click below for a recap of the application. #health #HCV #hepatitis

bit.ly/2lczWF9

Written by
HFIAdmin profile image
HFIAdmin
To view profiles and participate in discussions please or .

Not what you're looking for?

You may also like...

Worried

Hello, my husband took epclusa and he was undetected but then it came back after 12 week post...

In a state of despair....

Hi all i have just found out i have this this year and i managed to get to week 7 and i couldnt...

Finished Mavyret Treatment

Hello everyone!I finished my treatment 2 weeks ago and my last labs show the virus is...

Mavyret treatment

Hi Everyone! After 4 years of waiting for treatment I am starting my 8 weeks Mavyret treatment. I...

Hep C for over 25 years, maybe a lot longer

I was diagnosed with Hep C when I gave blood at the blood bank some 25 years ago. Who knows how...